KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Inventory Average (2019 - 2025)

Historic Inventory Average for BioNTech SE (BNTX) over the last 6 years, with Q3 2025 value amounting to $262.5 million.

  • BioNTech SE's Inventory Average fell 2490.57% to $262.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.5 million, marking a year-over-year decrease of 2490.57%. This contributed to the annual value of $343.8 million for FY2024, which is 1749.15% down from last year.
  • Per BioNTech SE's latest filing, its Inventory Average stood at $262.5 million for Q3 2025, which was down 2490.57% from $264.4 million recorded in Q2 2025.
  • BioNTech SE's Inventory Average's 5-year high stood at $545.2 million during Q1 2022, with a 5-year trough of $126.8 million in Q1 2021.
  • Over the past 5 years, BioNTech SE's median Inventory Average value was $371.8 million (recorded in 2022), while the average stood at $367.9 million.
  • As far as peak fluctuations go, BioNTech SE's Inventory Average skyrocketed by 32990.58% in 2022, and later tumbled by 2869.08% in 2025.
  • Over the past 5 years, BioNTech SE's Inventory Average (Quarter) stood at $126.8 million in 2021, then skyrocketed by 194.04% to $372.9 million in 2022, then rose by 12.29% to $418.7 million in 2023, then decreased by 24.1% to $317.8 million in 2024, then decreased by 17.4% to $262.5 million in 2025.
  • Its Inventory Average was $262.5 million in Q3 2025, compared to $264.4 million in Q2 2025 and $285.2 million in Q1 2025.